Not All Fillers Are Equal - Do You Know What You’re Getting?
Injectables are becoming a staple item on salon menus, but one of the world’s leading anti-ageing experts says not all fillers are equal.
Dr Maria Angelo-Khattar is a fellow of the Royal Society of Medicine UK, the clinical director of the Aesthetic Anti–Ageing Fellowship program of the American Academy of Anti-Ageing Medicine, and the founder of the Institute of Medical Aesthetics in Dubai.
She recently visited Australia to speak at the 8th Annual Australasian Academy of Anti-Ageing Medicine Conference: An Integrative Approach to Stress and Ageing, on the topic of ‘enhancing facial shape: a minimally invasive approach.’
Dr Angelo-Khattar says soft tissue fillers can be used for the restoration of volume in an ageing face and the enhancement of beauty in a young face by augmenting cheeks, correcting asymmetry and creating chin projection where necessary.
One of those soft tissue fillers is Polycaprolactone (trade name Ellansé by Sinclair Pharmaceuticals, UK).
“It’s a collagen stimulating filler substance that yields very natural, long-lasting correction of the face,” Dr Angelo-Khattar says.
Dr Angelo-Khattar believes patients are becoming sick of other types of injectables, such as Hyaluronic acid fillers, that require ‘topping up’ every six months.
“I truly believe that it is possible to greatly delay ageing by the use of collagen stimulating substances such as Ellansé, since the procedure allows the body to eventually perform its own filling whereby the polycaprolactone induces new collagen formation and is ultimately eliminated from the body, being replaced by the persons own soft tissue,” she says.
“The whole strategy is one of natural rejuvenation . Furthermore, even the shortest acting formulation of it, the “S” lasts one and a half to two years, resulting in a long-lasting correction.”
Dr Angelo-Khattar says advances in non-surgical techniques are resulting in a decline in invasive surgical procedures, especially when it comes to facial rejuvenation.
“This is due to the advent of a plethora of evidence-based minimally invasive procedures and the fact that patients are become much better informed by the media about their options in this regards,” she says.
“Moreover, many individuals are opting to have age delaying treatments at a younger age and are hence able to ward off the ravages of time and environmental damage much more effectively than in the past.
“Apart from corrections in facial shape, the vast majority of patients want to improve their skin quality, reduce pigmentation as well as lines and wrinkles.”
About the author
Maria Angelo-Khattar completed her MD., PhD, MSc, Pharmacology and Dermatolgy degrees at Kings College , St. Mary’s Medical School, and University of London before she founded the Aesthetica Clinic. She is currently the managing director and training director of Aesthetica Clinic, where she trains medically qualified practitioners for Aesthetica clinic. And because of her expertise, she’s always been invited to lecture at various international congresses.